Kaplan SA - Search Results

1

Randomized, double-blind, placebo controlled pilot study of intradetrusor injections of onabotulinumtoxinA for the treatment of refractory overactive bladder persisting following surgical management of benign prostatic hyperplasia.

Chughtai B, Dunphy C, Lee R, Lee D, Sheth S, Marks L, Kaplan SA, Te AE. Chughtai B, et al. Among authors: kaplan sa. Can J Urol. 2014 Apr;21(2):7217-21. Can J Urol. 2014. PMID: 24775575 Clinical Trial.

2

PSA response to finasteride challenge in men with a serum PSA greater than 4 ng/ml and previous negative prostate biopsy: preliminary study.

Kaplan SA, Ghafar MA, Volpe MA, Lam JS, Fromer D, Te AE. Kaplan SA, et al. Urology. 2002 Sep;60(3):464-8. doi: 10.1016/s0090-4295(02)01760-0. Urology. 2002. PMID: 12350485 Clinical Trial.

3

A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome.

Kaplan SA, Volpe MA, Te AE. Kaplan SA, et al. J Urol. 2004 Jan;171(1):284-8. doi: 10.1097/01.ju.0000101487.83730.80. J Urol. 2004. PMID: 14665895 Clinical Trial.

4

Efficacy of antimuscarinic therapy for overactive bladder with varying degrees of incontinence severity.

Landis JR, Kaplan S, Swift S, Versi E. Landis JR, et al. J Urol. 2004 Feb;171(2 Pt 1):752-6. doi: 10.1097/01.ju.0000103540.71683.e5. J Urol. 2004. PMID: 14713803 Clinical Trial.

5

Use of alpha-adrenergic inhibitors in treatment of benign prostatic hyperplasia and implications on sexual function.

Kaplan SA. Kaplan SA. Urology. 2004 Mar;63(3):428-34. doi: 10.1016/j.urology.2003.09.063. Urology. 2004. PMID: 15028431 Review. No abstract available.

6

Long-term pooled analysis of multicenter studies of cooled thermotherapy for benign prostatic hyperplasia results at three months through four years.

Trock BJ, Brotzman M, Utz WJ, Ugarte RR, Kaplan SA, Larson TR, Blute ML, Roehrborn CG, Partin AW. Trock BJ, et al. Among authors: kaplan sa. Urology. 2004 Apr;63(4):716-21. doi: 10.1016/j.urology.2003.11.006. Urology. 2004. PMID: 15072887

7

Transurethral microwave thermotherapy for benign prostate hyperplasia: separating truth from marketing hype.

Walmsley K, Kaplan SA. Walmsley K, et al. Among authors: kaplan sa. J Urol. 2004 Oct;172(4 Pt 1):1249-55. doi: 10.1097/01.ju.0000129967.30558.ca. J Urol. 2004. PMID: 15371817 Review.

8

Benign prostatic hyperplasia: now we can begin to tailor treatment.

Gjertson CK, Walmsley K, Kaplan SA. Gjertson CK, et al. Among authors: kaplan sa. Cleve Clin J Med. 2004 Nov;71(11):857, 860, 863-5 passim. doi: 10.3949/ccjm.71.11.857. Cleve Clin J Med. 2004. PMID: 15570735 Free article. Review.

9

High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates.

Sandhu JS, Ng C, Vanderbrink BA, Egan C, Kaplan SA, Te AE. Sandhu JS, et al. Among authors: kaplan sa. Urology. 2004 Dec;64(6):1155-9. doi: 10.1016/j.urology.2004.07.018. Urology. 2004. PMID: 15596189 Clinical Trial.

10

Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia.

Kaplan SA. Kaplan SA. J Urol. 2005 Sep;174(3):1011. doi: 10.1097/01.ju.0000171855.70549.4e. J Urol. 2005. PMID: 16094031 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,014 results

Search Page

Filters